share_log

宁波美诺华药业股份有限公司关于全资子公司获得氨溴特罗口服溶液药品注册证书的公告

Announcement of Ningbo Menova Pharmaceutical Co., Ltd. on the wholly-owned subsidiary obtaining a drug registration certificate for ambromoterol oral solution

SZSI ·  Oct 31, 2024 00:00

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.